Truepoint, Inc.

CIK 0001427748 · CINCINNATI, OH · Quarter end: 2026-06-30 · Filed on: 2026-07-31 · Open the SEC source

Truepoint, Inc. reported 160 positions worth $4.79B as of June 30, 2026 (13F filed July 31, 2026). Largest holding: BSV (12.1%).

Portfolio Value (AUM)Total value of the fund's US stock portfolio reported to the SEC.
$4.79B
2026 Q2
Positions
160
Top-10 ConcentrationHow much of the portfolio sits in the 10 largest holdings. High = concentrated bets.
73.8%
Est. Net Flow (Q)
2026 Q2
10 / 160 positions shown
#SymbolCompanyTypeValue% Port.Shares1YYTD
1BSVVANGUARD BD INDEX FDSSH$578.1M12.07%7,420,247
2DFCFDIMENSIONAL ETF TRUSTSH$568.9M11.87%13,477,146
3IVVISHARES TRSH$502.5M10.49%671,007
4VTIVANGUARD INDEX FDSSH$424.7M8.86%1,147,607
5VOTVANGUARD INDEX FDSSH$334.9M6.99%1,093,223
6AVUVAMERICAN CENTY ETF TRSH$331.1M6.91%2,653,956
7VEAVANGUARD TAX-MANAGED INTL FDSH$227.2M4.74%3,188,877
8VUGVANGUARD INDEX FDSSH$210.6M4.40%2,445,104
9DFEMDIMENSIONAL ETF TRUSTSH$201.7M4.21%4,964,110
10DFNMDIMENSIONAL ETF TRUSTSH$155.2M3.24%3,211,719

The free plan shows the top 10 positions. The remaining 150 positions, the full portfolio and quarter changes unlock with Pro.

Pro Feature

This section is exclusive to Fundocap Pro. Full holdings tables, consensus trades, ownership analysis, backtests and exports unlock with Pro.

Upgrade to Pro

Read the 2026-Q2 quarterly report · 13F Filing Calendar

Frequently Asked Questions

What stocks does Truepoint, Inc. hold as of Q2 2026?

Truepoint, Inc. reported 160 positions worth $4.79B in its Q2 2026 13F filing. Largest positions: BSV (12.1%), DFCF (11.9%), IVV (10.5%), VTI (8.9%) and VOT (7.0%).

What did Truepoint, Inc. buy in Q2 2026?

No previous quarter is available yet; the comparison appears with the next filing.

What did Truepoint, Inc. sell in Q2 2026?

No previous quarter is available yet.

13F data shows quarter-end positions, is delayed by up to 45 days and covers only long positions in US-listed securities; short positions, most derivatives and non-US assets are not reported.